Hematology oncology treatment in Israel typically costs between $13,100 and $151,300. Prices vary based on the specific diagnosis, the complexity of the treatment protocol, and whether the facility is public or private. International patients often find savings of 30-80% compared to the United States for advanced procedures.
Typical Hematology Oncology Costs in Israel
Major medical centers located in Tel Aviv, Ramat Gan, and Jerusalem lead the field in specialized oncology care. While treatment costs are generally consistent across these hubs, private centers in Tel Aviv might differ in pricing structure. Consult with a specialist to get accurate pricing for your specific medical needs.
| Israel | Turkey | Austria | |
| Therapeutic Apheresis | ≈ $1,400 | ≈ $1,400 | ≈ $1,800 |
| Selective Apheresis | ≈ $2,800 | ≈ $1,600 | ≈ $1,800 |
| Plasmapheresis | ≈ $2,200 | from $2,600 | ≈ $2,000 |
| Plasma Exchange | ≈ $4,500 | ≈ $3,900 | ≈ $3,800 |
| Lymphoma chemotherapy | from $1,400 | from $3,000 | ≈ $8,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Hematology Oncology treatment upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hematology Oncology treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hematology Oncology treatment journey.
Head of Hematology at Sourasky Medical Center – Israel's premier hospital for blood cancer care.
Several hundred stem cell transplants performed – Dr. Ram specializes in complex hematologic cases at Sourasky Medical Center.
300+ pediatric bone marrow and umbilical blood transplants – Dr. El Hasid leads the Pediatric Oncohematology Department at Dana Dwek Children's Hospital.
Dr. Amos Toren is a pediatric hemato-oncologist at Sheba Medical Center. He served as Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant Division. Dr. Toren holds a PhD in Human Genetics. He specializes in CAR T-cell therapy and bone marrow transplantation for children. Forbes Israel has recognized his expertise in hematology.
Written by Anna Leonova
Written by Anna Leonova
Written by Halina Shubala
Israel is a global leader in hematology-oncology for blood cancer treatment. Top centers like Sourasky Medical Center report a 90% success rate in oncology. Patients access advanced therapies like CAR T-cell and bone marrow transplants faster than in many other countries. Facilities hold prestigious Joint Commission International (JCI) accreditation.
Bookimed Expert Insight: Our data shows that top Israeli hospitals like Sheba and Sourasky operate at massive scales. Sheba handles 1,500,000+ patients annually across 1,990 specialties. This high volume allows doctors to gain deep experience in rare blood cancers. We notice patients often choose these centers specifically for complex cases that other systems might turn away.
Patient Consensus: Patients note that initial consultations happen much faster in Israel than in Europe or North America. They emphasize the importance of requesting itemized costs and planning for multiple trips for treatment evaluations.
Advanced blood cancer treatments in Israel include CAR T-cell therapy, targeted molecular therapies, and hematopoietic stem cell transplantation. These options treat aggressive lymphomas, multiple myeloma, and leukemias. Leading centers offer precision medicine and haploidentical transplants. Specialized care is available for both adult and pediatric patients.
Bookimed Expert Insight: Israeli hematology centers show a unique pattern of high-volume specialization. Dr. Polina Stepensky at Hadassah Medical Center has performed 3,500+ bone marrow transplants. Sheba Medical Center has over 35 years of experience in this field. This deep expertise allows these clinics to manage rare blood diseases that other facilities might not handle routinely.
Patient Consensus: Patients note that Israeli doctors prioritize aggressive treatment and clinical trials over passive monitoring. They emphasize the importance of quick coordination for urgent procedures like CAR T-cell therapy.
Israeli oncologists determine treatment regimens through multidisciplinary tumor boards and advanced genomic profiling. Specialists at JCI-accredited centers like Sourasky Medical Center (Ichilov) and Hadassah Medical Center align protocols with international standards. Decisions integrate molecular diagnostics, patient age, and clinical trial eligibility to personalize care plans.
Bookimed Expert Insight: Israeli oncology stands out because top specialists often hold dual roles as researchers and clinicians. At Hadassah Medical Center, Dr. Polina Stepensky has performed 3,500+ transplants, directly applying lab innovations to patient bedside care. This crossover allows patients to access experimental therapies, like CAR-T, much faster than in many European systems.
Patient Consensus: Patients emphasize that genomic testing is fast-tracked and essential for choosing the right drugs. Many note that bringing family to consultations is culturally expected and helps in making shared treatment decisions.
Eligibility for clinical trials in Israel depends on specific inclusion criteria like age, disease stage, and genetic markers. Patients often qualify for hematology oncology trials at JCI-accredited centers. These facilities use advanced protocols for leukemia, lymphoma, and multiple myeloma including CAR T-cell therapy.
Bookimed Expert Insight: Data from Hadassah and Sourasky (Ichilov) shows that patients with rare mutations often secure compassionate use slots even if standard trials are full. Specialists like Dr. Ilia Kirshner have led phase III trials, and choosing a clinic with high surgical volumes, like Sourasky performance of over 1,800,000 patient visits annually, often provides better access to emerging protocols.
Patient Consensus: Patients note that contacting principal investigators directly with full pathology reports speeds up the process. Many suggest budgeting for a 2-week screening trip as on-site testing often reveals new eligibility options.
Hematology oncology treatment in Israel starts within 1 to 7 days for urgent cases. Routine procedures typically begin within 7 to 10 days of arrival. JCI-accredited centers like Sourasky Medical Center (Ichilov) use fast-track programs to accelerate diagnostics for international patients.
Bookimed Expert Insight: High-volume centers like Sheba Medical Center handle over 1.5 million patients annually. Their massive infrastructure allows them to operate in-house cord blood banks and specialized labs. This independence from external providers often cuts the waiting time for complex cell therapies by several days compared to smaller facilities.
Patient Consensus: Patients note that arriving with pre-translated medical records significantly speeds up the process. They emphasize that while the medical system moves quickly, scheduling around Shabbat or local holidays is essential to avoiding minor 1-day delays.
Patients in Israel commonly experience fatigue, nausea, and low blood counts during hematology oncology treatments. Specialist centers manage these via proactive medication protocols and expert nursing support. Most side effects are temporary and respond well to clinical interventions like growth factor injections or targeted anti-emetics.
Bookimed Expert Insight: Israeli hematology centers like Sourasky Medical Center (Ichilov) and Hadassah offer unique efficiency through home-based supportive care. Data shows clinics often coordinate nurse visits for home injections and medication delivery. This approach minimizes hospital stays and reduces the risk of secondary infections for immunocompromised patients.
Patient Consensus: Patients note that while fatigue is intense, the 24/7 clinic hotlines and walk-in access for blood transfusions provide significant peace of mind. Using Hebrew translation apps for pharmacy discussions and staying extremely hydrated are top recommendations from those treated in Israel.
Israel manages international hematopoietic stem-cell transplants and CAR-T therapies through specialized departments at JCI-accredited centers. These facilities coordinate diagnostics, cell harvesting, and intensive monitoring. Centers like Sheba Medical Center and Sourasky Medical Center provide integrated logistics including medical visa sponsorship and English-speaking staff.
Bookimed Expert Insight: While many believe choosing a hospital is only about the surgeon, our data shows that for cell therapies, the laboratory is equally vital. Clinics like Sheba Medical Center and Sourasky Medical Center utilize on-site manufacturing labs. This capability can reduce CAR-T production time to just 10–11 days. For international patients, this shorter window significantly lowers the total cost of their stay in Israel.
Patient Consensus: Patients note it is important to start the coordination process 2 to 3 months early to secure visa sponsorship. They often suggest budgeting for 1 to 3 months of stay due to isolation rules and follow-up requirements.
Israel's premier hospitals for hematologic oncology include Sheba Medical Center, Hadassah Medical Center, and Sourasky Medical Center. These institutions hold JCI accreditation and Newsweek rankings. They specialize in high-volume marrow transplants, CAR T-cell therapy, and complex leukemia treatments for international patients.
Bookimed Expert Insight: Data shows a strong correlation between high patient volumes and specialized success at Sheba Medical Center. It handles over 1,500,000 patients annually. This massive scale allows their specialists, like Dr. Arnon Nagler, to refine rare procedures such as cord blood transplantations. Choosing a facility with over 100 specialized departments often ensures smoother transitions between diagnostics and intensive therapy.
Patient Consensus: Patients note that central hubs in Jerusalem and Tel Aviv are preferred for complex blood disorders. They emphasize that starting the second opinion process early is vital for coordinating specialized care at these major institutions.
Israeli hematology-oncology centers follow mandatory Ministry of Health (MoH) licensing and international safety benchmarks. Leading facilities like Sheba Medical Center and Sourasky Medical Center (Ichilov) hold Joint Commission International (JCI) accreditation. These standards ensure rigorous clinical protocols and high patient safety levels.
Bookimed Expert Insight: Israeli centers demonstrate a unique pattern of high-volume specialty expertise. Sheba Medical Center serves 1,900,000 patients annually and performs 45,000+ operations. This massive volume allows departments to refine complex protocols like CAR T-cell therapy. Clinics with such high patient loads usually maintain the strictest infection control standards.
Patient Consensus: Patients note that Israeli oncology protocols strictly match international guidelines like NCCN. Some emphasize that top facilities maintain world-class care standards even during regional conflicts by using on-site shelters.
Suitable candidates for bone marrow transplants in Israel include patients with high-risk leukemia, multiple myeloma, or relapsed lymphoma. Doctors evaluate eligibility based on disease type, organ function, and donor availability. Israeli centers like Sourasky Medical Center (Ichilov) and Sheba Medical Center follow strict international clinical standards for selection.
Bookimed Expert Insight: Israeli oncology centers like Hadassah Medical Center and Sheba Medical Center provide a unique advantage by integrating local donor registries with the global National Marrow Program. This connectivity significantly increases the chance of finding a match for international patients. Furthermore, clinics with high patient volumes, such as Hadassah with 1,000,000 annual visits, often maintain specialized pediatric units for rare blood disorders.
Patient Consensus: Patients emphasize the importance of completing a full medical workup, including heart and lung tests, before arriving. Many note that preparing for a 4 to 6-week hospital stay is a practical reality of the intensive recovery process.
Recovery after stem-cell transplantation in Israel typically spans 12 to 24 months for full immune restoration. Engraftment usually occurs between days 10 and 21. Patients remain hospitalized for 3 to 6 weeks. Long-term monitoring focuses on infections and Graft-versus-Host Disease (GVHD).
Bookimed Expert Insight: Israeli centers like Sheba and Hadassah achieve high volumes, performing thousands of transplants. Data shows that clinics with specialized departments, such as the one led by Dr. Ron Ram at Sourasky, often utilize in-house molecular labs. This infrastructure allows for faster detection of CMV reactivation. Detecting these regional infections early significantly improves long-term survival rates for international patients.
Patient Consensus: Patients note that mental recovery often lags behind physical healing, with many experiencing a difficult emotional period around month 3. They recommend keeping a daily symptom journal to help doctors manage steroid-induced mood swings or persistent fatigue.
Israeli medical centers provide professional interpretation and logistical support for international hematology-oncology patients. Facilities like Sourasky Medical Center and Sheba Medical Center offer dedicated services in English, Russian, and Arabic. These services cover complex consultations for bone marrow transplantation and CAR T-cell therapy to ensure patient safety.
Bookimed Expert Insight: Israeli hospitals like Sheba and Sourasky handle massive patient volumes, with Sheba serving 1,500,000 people annually. Our data shows that because these are large academic institutions, they have permanent in-house translation departments. This is a major advantage over smaller clinics where you might wait days for a freelance interpreter to arrive for your results.
Patient Consensus: Patients note that while Russian and English support is very common, it is wise to confirm interpreter availability for specific appointment times. Many suggest looking into local NGOs like Ezer Mizion, which can sometimes help with specialized transport or additional community support during long stays.
Israel hosts several global transplant and cellular therapy hubs for international patients, primarily in Tel Aviv, Jerusalem, Ramat Gan, and Haifa. These JCI-accredited centers specialize in bone marrow transplantation (BMT) and CAR T-cell therapy. Leading institutions include Sheba Medical Center, Hadassah Medical Center, and Sourasky Medical Center (Ichilov).
Bookimed Expert Insight: Israeli centers like Sheba and Sourasky operate 1,500 to 2,000 beds. This high volume allows for dedicated pediatric subdivisions. Dr. Polina Stepensky at Hadassah has performed 3,500+ transplants alone. Patients should choose clinics with on-site cell manufacturing to reduce treatment wait times significantly.
Patient Consensus: Patients emphasize the need to plan for a 4–6 week stay. They also recommend having all medical records translated into English or Hebrew before arriving for treatment.
Israeli hematology-oncology centers typically operate on a direct-pay basis for international patients. Facilities like Sourasky Medical Center (Ichilov) and Hadassah Medical Center require upfront payment via wire transfer or credit card. Patients then submit detailed invoices to their insurers for reimbursement after treatment.
Bookimed Expert Insight: Our data shows that while public centers like Rambam Medical Center serve nearly 1,000,000 patients annually, they rarely bill foreign insurers directly for elective oncology. Private facilities like Assuta Medical Center offer more flexibility in choosing a specific attending physician. This choice is vital because having a primary doctor facilitates the detailed medical necessity letters required for insurance appeals.
Patient Consensus: Patients note that even with high-end international coverage, they usually pay the full amount out of pocket first. They recommend getting all medical documents translated into English immediately to speed up the reimbursement process with their home providers.
Israel is a premier neurosurgery hub due to its fusion of high-density medical innovation and elite surgical expertise. Top facilities like Sheba Medical Center integrate AI-guided navigation and real-time intraoperative MRI. Specialized centers report 98% success rates for complex procedures including awake craniotomy and movement disorder treatments.
Bookimed Expert Insight: Data shows a clear divide between public and private options in Israel. Private centers like Assuta Medical Center perform over 92,000 operations annually and allow patients to select their specific lead surgeon. This is a vital advantage for complex cases where a specific expert like Dr. Eli Ashkenazi is preferred for his 1,000+ spine surgery record.
Patient Consensus: Patients emphasize bringing original imaging on a USB for local review to streamline the surgical plan. They also note that private packages often include hotel coordination and airport transfers, making the logistics much smoother.
Israeli neurosurgeons treat a full spectrum of conditions ranging from brain and spinal tumors to complex functional disorders. Specialized centers utilize advanced technologies like Gamma Knife, deep brain stimulation, and intraoperative MRI to manage epilepsy, Parkinson disease, and cerebrovascular pathologies with high precision.
Bookimed Expert Insight: Israeli hospitals often combine specialties to handle complex cases. At Sourasky Medical Center, neurosurgeons like Dr. Zvi Lidar bridge neurosurgery and orthopedics for spinal care. This multidisciplinary approach allows clinics to perform 34,000+ operations annually. Choosing a facility with this crossover expertise often leads to more comprehensive treatment plans for degenerative diseases.
Patient Consensus: Patients value the ability to access specialized treatments like fluorescence-guided surgery for tumors which are often unavailable elsewhere. Many note that the staff is fluent in English and provides clear communication through teleconsultations before traveling.
Israel is home to world-renowned neurosurgery centers like Sourasky Medical Center, Sheba Medical Center, and Hadassah Medical Center. These facilities are globally ranked for treating complex brain tumors, spinal disorders, and movement diseases. They utilize advanced technologies like Gamma Knife, robotic systems, and intra-operative MRI.
Bookimed Expert Insight: Our data shows that while most patients focus on Tel Aviv, Rambam Medical Center in Haifa offers unique expertise in neuro-trauma. It operates a specialized neuro-ICU and serves nearly 1 million patients annually. This makes it an essential choice for complex post-trauma brain surgeries that requires intensive recovery support.
Patient Consensus: Patients note it is important to start consultations early. They often highlight that the precision and follow-up care for complex brain tumors exceeded their expectations. One patient emphasized how quickly they could connect with top professors for second opinions during critical neurosurgical cases.
Israel's leading neurosurgeons include Prof. Zvi Ram, Prof. Shlomi Constantini, and Prof. Itzhak Fried at Sourasky Medical Center. These specialists hold leadership roles in the European Association of Neurosurgical Societies (EANS) and the World Society for Stereotactic and Functional Neurosurgery (WSSFN). They utilize advanced intraoperative mapping and robotic systems.
Bookimed Expert Insight: Data from Sourasky and Sheba indicates a strong correlation between high surgical volumes and patient safety. For example, Sourasky performs 34,000+ operations annually with a 90% oncology success rate. Patients seeking complex tumor removals should prioritize centers like these where surgeons perform hundreds of specific cases each year.
Patient Consensus: Patients emphasize the importance of finding a surgeon who specializes specifically in your condition rather than a generalist. Many note that high-volume centers provide better access to English-speaking staff and coordinated care for international visitors.
International neurosurgery patients in Israel must provide comprehensive medical records including recent MRI or CT scans translated into English. Admission requires a clinical review by specialists to confirm treatment feasibility. Hospitals often mandate full advance payment or a significant deposit before confirming surgery dates or issuing visa support letters.
Bookimed Expert Insight: Data shows that top Israeli facilities like Sheba Medical Center and Hadassah Medical Center handle massive patient volumes, exceeding 1,000,000 people annually. This high demand means clinics prioritize complex or rare cases over routine procedures. Patients with unique or high-risk conditions often receive faster admission approval than those seeking standard treatments available elsewhere.
Patient Consensus: Patients note that having all imaging results ready in English is essential for quick scheduling. Many emphasize that while the medical care is excellent, coordinating around Shabbat closures is necessary to avoid unexpected diagnostic delays.
A standard stay for neurosurgery in Israel ranges from 10 to 14 days for uncomplicated cases. Patients undergoing complex procedures like brain tumor removal or deep brain stimulation often require 4 to 6 weeks. This timeline covers pre-operative diagnostics, the surgical procedure, and essential post-operative monitoring.
Bookimed Expert Insight: Data from Sourasky Medical Center shows they treat over 400,000 patients annually with high success rates. Clinics with such high volumes, like Hadassah or Assuta, often have streamlined discharge protocols. This helps international patients transition to hotel-based recovery faster while maintaining access to top specialists.
Patient Consensus: Patients note it is vital not to rush home too early. Some travelers extended their stay to 3 weeks due to swelling or to ensure they received final surgeon clearance before flying.
Israeli neurosurgery uses robotic guidance, real-time 3D imaging, and incisionless technologies to minimize physical trauma. Systems like Mazor Robotics provide sub-millimeter precision for spine implants. MRI-guided focused ultrasound (MRgFUS) treats tremors without incisions. These advanced tools ensure high accuracy and reduce recovery times.
Bookimed Expert Insight: Israeli clinics like Sourasky or Hadassah integrate proprietary Israeli-born technologies like Surgical Theater before they hit global markets. Our data shows these centers often use VR flight-through models for pre-surgical planning. This allows surgeons to rehearse complex cases, which is a key factor in their 90% success rates.
Patient Consensus: Patients note that technologies like the Gamma Knife allowed them to return home in days rather than weeks. Many move from traditional 10cm incisions to cuts under 2cm when using robotic-assisted systems.
Israel is a global leader in neurosurgery due to its integration of proprietary medical innovations and internationally trained specialists. High-capacity centers like Sourasky Medical Center (Ichilov) perform over 34,000 annual surgeries. Patients access advanced techniques like awake craniotomy and MR-guided focused ultrasound.
Bookimed Expert Insight: Israeli neurosurgery stands out because of the high concentration of dually certified experts. Many top surgeons, such as Dr. Zvi Lidar, are certified to practice in both Israel and the USA. This ensures that patients receive American-standard surgical care while staying in Tel Aviv or Jerusalem. Our data shows that private centers like Assuta offer significantly faster access to these specific specialists compared to the public system.
Patient Consensus: Patients note it is important to confirm a surgeon's specific volume of cases for your exact condition. They also value the ability to get expert second opinions quickly through online consultations with world-renowned professors.
Sheba Medical Center and Sourasky Medical Center (Ichilov) are among the best neurosurgery hospitals in Israel. These JCI-accredited facilities perform thousands of operations annually. They utilize advanced technologies like CyberKnife and intraoperative MRI to treat complex brain tumors and cerebrovascular lesions.
Bookimed Expert Insight: Our data shows that top Israeli centers like Sourasky and Hadassah perform over 40,000 total operations yearly. This high volume allows surgeons to maintain a 90% success rate even in complex oncology cases. Patients seeking robotic spine surgery or deep brain stimulation should focus on these high-capacity municipal centers for the most experienced teams.
Patient Consensus: Patients appreciate that some hospitals quickly coordinate consultations even during regional strikes. Families of pediatric patients especially value surgeons trained at prestigious international institutions.
Israel's leading neurosurgeons include Professor Zvi Ram, Professor Shlomi Constantini, and Professor Itzhak Fried at Sourasky Medical Center. These experts specialize in awake craniotomy, pediatric brain tumors, and functional mapping. Most hold JCI accreditation and international fellowships from institutions like Johns Hopkins and Yale.
Bookimed Expert Insight: Data shows that top-tier Israeli neurosurgeons, such as those at Sourasky Medical Center, often hold dual board certifications in Israel and the US. This unique crossover ensures patients receive American-standard protocols. These specialists typically manage over 34,000 annual operations, providing high-volume clinical experience that smaller private clinics cannot match.
Patient Consensus: Patients note that highly qualified doctors like Professor Shlomo Constantini provide satisfactory answers quickly. People emphasize that outcomes often depend on the hospital’s integrated resources rather than just a doctor's prestige.
Israel is a global leader in neurosurgery, treating complex brain and spinal conditions using robotic-assisted and minimally invasive techniques. Highly specialized units at JCI-accredited centers like Sourasky Medical Center (Ichilov) and Hadassah Medical Center focus on neuro-oncology, pediatric neurosurgery, and functional procedures.
Bookimed Expert Insight: Israeli neurosurgical departments often function as rapid-response hubs for international patients. Data shows that large centers like Sourasky, which serves 1,800,000 patients annually, can organize expert video consultations in a very short time. This speed is critical for neuro-oncology cases where starting treatment a few days earlier significantly impacts outcomes.
Patient Consensus: Patients note that Israeli teams often accept high-risk cases that other hospitals decline. They emphasize the importance of using local coordinators to manage travel logistics or potential local disruptions during their two-week stay.
International patients traveling to Israel for neurosurgery require a valid passport, an entry permit or medical visa, and a formal hospital invitation. You must provide recent MRI or CT scans in DICOM format and detailed medical summaries. Proof of private health insurance and financial stability are also mandatory for border entry.
Bookimed Expert Insight: Our data shows that top neurosurgeons at Hadassah Medical Center and Sourasky often request records 4–6 weeks before arrival. Submitting these early prevents appointment shifts. High-volume centers with over 30,000 annual operations have dedicated portals for secure DICOM file uploads. Using these ensures your surgeon reviews high-quality images before you land in Tel Aviv.
Patient Consensus: Patients emphasize bringing physical copies and digital backups of all scans on a USB drive. They also note that private insurance needs pre-authorization specifically for neurosurgery to avoid payment delays at the clinic.